Case report | Open | Open Peer Review | Published:
A case report of avian influenza H7N9 killing a young doctor in Shanghai, China
BMC Infectious Diseasesvolume 15, Article number: 237 (2015)
The novel avian influenza H7N9 virus has caused severe diseases in humans in eastern China since the spring of 2013. On January 18th 2014, a doctor working in the emergency department of a hospital in Shanghai died of H7N9 virus infection. To understand possible reasons to explain this world’s first fatal H7N9 case of a health care worker (HCW), we summarize the clinical presentation, epidemiological investigations, laboratory results, and prevention and control policies and make important recommendations to hospital-related workers.
The patient was a 31-year-old male Chinese surgeon who was obese and had a five-year history of hypertension and suspected diabetes. On January 11th 2014, he showed symptoms of an influenza-like illness. Four days later, his illness rapidly progressed with bilateral pulmonary infiltration, hypoxia and lymphopenia. On January 17th, the case had a high fever, productive cough, chest tightness and shortness of breath, so that he was administered with oseltamivir, glucocorticoid, immunoglobulin, and broad-spectrum antibiotic therapy. The case died in the early morning of next day after invasive ventilation. He had no contact with poultry nor had he visited live-poultry markets (LPMs), where positive rates of H7N9 were 14.6 % and 18.5 %. Before his illness, he cared for three febrile patients and had indirect contact with one severe pneumonia patient. Follow-up with 35 close contacts identified two HCWs who had worked also in emergency department but had not worn masks were anti-H7N9-positive. Viral sequence identity percentages between the patient and two LPM-H7N9 isolates were fewer than between the patient and another human case in shanghai in January of 2014.
Important reasons for the patient’s death might include late treatment with oseltamivir, and the infected H7N9 virus carrying both mammalian-adapted signature (HA-Q226L) and aerosol transmissibility (PB2-D701N). The LPM he passed every day was an unlikely source of his infection, but a contaminated environment, or an unidentified mild/asymptomatic H7N9 carrier were more probable. We advocate rigorous standard operating procedures for infection control practices in hospital settings and evaluations thereafter.
The first human avian influenza H7N9 case was reported in Shanghai in February 2013 . By the end of 2013, Shanghai had 33 laboratory-confirmed human H7N9 cases, with a higher case fatality rate (CFR) than observed nationally [54.6 % (18/33) versus 32.6 %, (47/144)]. As of September 27th 2014, Shanghai had an additional 8 cases with 7 fatalities [CFR in 2014: 87.5 % (7/8) versus 42.2 %, (125/296)]. Two family clusters were noted in Shanghai, indicating limited person-to-person transmission . On January 18th 2014, the first HCW succumbed to H7N9. In this report, we summarize the clinical presentation, epidemiological investigations, laboratory results, and prevention and control policies and make recommendations.
The case under consideration in this article is a 31-year-old male surgeon working in the emergency department (ED) of a Pudong hospital in Shanghai (SH-PDH), China. He was obese (BMI: 29.39, ≥28 in China ), with a five-year history of hypertension and suspected diabetes, and was a non-smoker. There was no history of previous drug or food allergies or blood transfusions.
On January 11th 2014, the patient showed symptoms of an influenza-like illness (ILI) (fever, cough, sore throat, dizziness, headache and myalgia) and self-treated with Analginum (Fig. 1). Four days later, the surgeon sought medical care and took mezlocillin only. From January 11th to January 16th, he continued working (~8 hours a day) at the hospital until he developed dyspnea. He was not treated with oseltamivir prior to his admission into SH-PDH intensive-care-unit (ICU) on January 17th. His illness rapidly progressed with bilateral pulmonary infiltration, hypoxia and lymphopenia. Oxygen therapy and mechanical ventilation were started. Additionally, oseltamivir (75 mg orally and 150 mg intra-gastrically), glucocorticoid, immunoglobulin and broad-spectrum antibiotics therapy (imipenem and vancomycin, 1 g intravenously every 12 hours) were administered. At 8:00 AM on January 17th, he had a fever (39 °C), productive cough, chest tightness and shortness of breath. The white blood cell count was 6.20 × 109/L with 83.4 % neutrophils and 14.5 % lymphocytes (Table 1). A computed tomography chest scan showed consolidation in both lungs (Fig. 2). At 8:47 AM, the patient was given non-invasive ventilation but he continued to suffer from hypoxaemia. As his condition worsened, he was started on invasive ventilation with positive end-expiratory pressure at 11:28 AM. The patient died of acute respiratory distress syndrome, severe pneumonia, and type I respiratory failure at 4:59 AM on January 18th.
Field epidemiology investigation
Retrospective investigation showed that X lived with his six family members (including his 7-month-pregnant wife) in a 112-m2-sized house without birds or other animals. Although he had not visited LPMs, he usually rode a bicycle to work and passed by the LPM -A where bird feces were spread on the road near the market gate. His mother-in-law did grocery shopping at the LPM-B which is 2.5 miles from X’s home almost every day. One of his neighbors owned about 14 pigeons. On January 19th-20th, 2014, six pigeon-related samples (2 poultry feces, 1 throat swab, 1 drinking water, 1 polluted water, and 1 swab of cage) from X’s neighbor and 68 LPM-associated samples collected from LPM-related samples [including throat/anal swabs, and feces of poultry and environmental specimens (chicken cages, cutting boards, water from washing poultry flowing on the floor)] were tested by real-time reverse-transcriptase-polymerase-chain-reaction (rRT-PCR) . The results showed that the positive rates of H7N9 were 14.6 % (6/41), 18.5 % (5/27), and 0 % (0/6) from LPM-B-, LPM-A- and pigeon-related specimens, respectively. Ten days before the onset of X’s illness, all six family members were asymptomatic and no guests had visited.
At the hospital (SH-PDH), the ED is a 400-m2 U-shaped emergency room, including six 10-m2-sized neighboring rooms, where neither windows nor systematic regular ventilation system were installed. The ER-A and ER-C (Fig. 3) consultation rooms were used by the Departments of Surgery and Internal Medicine, respectively. In the 10 days before disease onset, X took care of 187 surgical patients in ER-A1. Three of X’s patients who developed febrile illness and recovered completely were migrants lost to follow-up. Further investigations revealed that two other patients who had sought medical care in ER-C during January 1st-10th 2014 had also died. One was a ninety-seven-year-old man with chronic obstructive pulmonary disease (COPD-1) who arrived at ER-C on January 7th, talked with an ED-internist (Dr.-A1), was immediately hospitalized [cared for by 3 doctors (Drs.-A2, A3, and A4) and one nurse (N-A1)], and died the next day. The other was an eighty-eight-year-old woman with severe pneumonia (SP-1) who went to ER-C on January 5th, consulted an ED-internist Dr.-B1, was subsequently hospitalized (cared for by Drs.-B2, B3, and B4, and N-B1), and died on January 8th from an infection that was not identified. Specimens from 10 persons [COPD-1, SP-1, 8 HCWs except Dr.-A1 andDr.-B1] were not available for H7N9 tests. Follow-up of all 10 HCWs who had direct contact with COPD-1 and SP-1 showed that none of them became ill (no fever/cough/pneumonia) between January 10th 2014 and January 20th 2014. In addition, both the throat and blood specimens collected on January 20th from Dr.-A1 and Dr.-B1 in ER-C, who shared the same space or air with X in ER-A1, were H7N9-negative.
Identification and Tracing of close contacts
In our investigation of human-to-human transmission, we defined close contacts of X as those who had direct contact but without taking any personal protective equipment (PPE) between January 11th and January 18th. In total, 35 close contacts of X were identified for daily monitoring, including 9 family members (3 visited him at the hospital but lived separately) and 26 HCWs [11, 10, 2, and 3 from ED, ICU, radiology, and supporting staff, respectively]. None had respiratory or other H7N9-related symptoms within 10 days of their last exposure to X. On January 20th, we collected throat swabs for rRT-PCR, and all samples were H7N9-negative. Since serological surveillance provides more information on total infection, we then tested serum samples collected from all 35 close contacts by haemagglutination inhibition (HAI) assay , using influenza A/Anhui/1/2013 (H7N9) virus as a viral antigen and horse red blood cells. Furthermore, the two anti-H7N9-positive HCWs were investigated in detail. The HCW with a serotiter of 1:40 against the H7N9 virus was a 37-year-old male ED surgeon (Y), and the other one with a serotiter of 1:20 was a 30-year-old male ED internist (Z). These three HCWs (X, Y, and Z) did not care for the same patient from January 1st to January 17th. They had never worked in the ICU and did not have any overlapping encounters with patients of COPD-1 and SP-1. X and Y had worked together but had not worn masks in ER-A1 for two days (8 hours/day) on January 3rd and 15th January (4 days after the onset of X’s illness). In addition, X talked with Z in ER-B1 (for emergency handling of patients) for 10 minutes without their masks at 3:00 AM on January 17th before being admitted to the ICU. Sixteen environmental samples were collected from ER-A1 (the surface of telephone receiver, printer, work table, and medical waste), ER-B2 (rails of hospital beds, oxygen humidifier, sputum aspirator surface, ECG monitor wall, outer surface of IV stand), and ICU (ECG monitor wall, surface of blood pressure meter, outer surface of sputum aspirator, Infusion pump surface, stethoscope surface and rails of hospital beds). They were H7N9-negative by rRT-PCR.
Virology and associated molecular investigations
On January 18th 2014, the throat swab of X collected on the day of death was sent to Shanghai Municipal Center for Disease Control and Prevention, and confirmed as H7N9 by rRT-PCR on January 19th. Phylogenetic analysis for all eight H7N9 viral genomic segments was performed by both neighbour-joining (NJ) and maximum-likelihood (ML) methods with MEGA version 5.10. The reliability of the unrooted tree was assessed by bootstrap with 1000 replications. Bootstrap values greater than 60 % are shown for selected nodes. All the nucleotide sequences of the eight viral gene segments of X’s H7N9 virus (A/Shanghai/PD-02/2014, PD-2) are available at GenBank with the following accession numbers: KJ549801 (PB2), KJ549802 (PB1), KJ549803 (PA), KJ195797 (HA), KJ195798 (NP), KJ195799 (NA), KJ195800 (M), KJ195801 (NS).
The eight viral genes shared between X’s H7N9 virus (A/Shanghai/PD-02/2014, PD-2) and the avian-origin H7N9 virus isolates from the two LPMs in this study (A/Chicken/Shanghai/PD-CN-02/2014, CN-2 and A/Environment/Shanghai/PD-JZ-01/2014, JZ-1) revealed nucleic acid sequence identity percentages ranging from 97.8 % to 99.5 % (Table 2), in which the percentages of the PA gene ranked lowest (97.9 %, 97.8 %). However, the overall viral sequence identity was higher (ranging 98.1 % ~ 99.7 %) between the two Shanghai human cases, PD-2 and PD-1 (A/Shanghai/PD-01/2014, PD-1), while PD-1 was another non-epidemiologically linked H7N9 human case that was also confirmed in January in SH-PD. Similarly, viral sequence patterns for all the eight individual genes were also closer between PD-2 and PD-1 than those between PD-2 and CN-2 or JZ-1. GenBank accession numbers of PD-2, JZ-1, and CN-2 are as follows: PB2 (KJ549799, KJ549791, KJ549783), PB1 (KJ195791, KJ549792, KJ549784), PA (KJ549800, KJ549793, KJ549785), HA (KJ195792, KJ549794, KJ549786), NP (KJ195793, KJ549795, KJ549787), NA (KJ195794, KJ549796, KJ549788), M (KJ195795, KJ549797, KJ549789), NS (KJ195796, KJ549798, KJ549790).
The phylogenetic tree topology was the same, using ML and NJ methods; hence the results of MJ tree are displayed in Fig. 4. The results showed that all the four genes (HA, NA, M and NS) of PD-2 clustered with PD-1 (i.e. the same sub-lineage) whereas the two LPM-derived H7N9 isolates belonged to another sub-lineage. HA, PA, PB2, and NP of JZ-1 are at the same branch as those of PD-2. The PD-2 had more amino acid changes from avian to human signatures, with markers of mammalian-host adaptation , such as HA-Q226L HA-G228S (H3 numbering), and PB2-E627K. In contrast, CN-2 and JZ-1 isolates kept one avian-associated molecular signature with no change at PB2-E627 among these three amino acids. For clinical concern, the PD-2 virus was still oseltamivir-sensitive (NA-E119 , R292 , and N294 ) but Amantadine-resistant (M2-S31N) [1, 7]. Most importantly, of these four SH-H7N9 viruses, only the PD-2 possessed PB2-D701N (aerosol transmissibility in ferrets) [8, 9], which has public health significance.
The study was approved by the Ethical Committee of the Shanghai Municipal Center for Disease Control and Prevention.
We describe the world’s first case of a health care worker who died of H7N9 at the age of 31. This is much younger than the median age of 64 in 172 fatal H7N9 cases in China. Undoubtedly, the death of this young doctor could have several explanations. These include the fact that he suffered from hypertension, diabetes, and obesity. As of September 27th 2014, these three underlying conditions were also present in 27.3 %, 11.1 %, and 10.7 % of 172 fatal H7N9 cases (131 with BMI data) in China, respectively. Obesity was also a risk factor contributing to the severity of the 2009 H1N1 influenza pandemic cases in China and other areas [10–12]. Perhaps more importantly, the patient was late to seek treatment (4 days after disease onset)  since he was unaware of his infection with H7N9. As a result, treatment with oseltamivir was not begun until 6 days after the onset of illness, a time when the drug would be ineffective . Additionally, of critical importance, the patient was infected with a H7N9 virus that contained a mammalian-adapted signature (HA-Q226L), a mutation at PB2-D701N which facilitated its aerosol transmission as well as virulence markers (PB2-627 K and HA-G228S) [1, 14]. Taken together, along with the fact that the doctor had been working a seven-day shift with little rest since the onset of his disease, his lymphopenia indicating abnormal immunity [13, 15], and possibly unidentified accumulated exposures, these factors could explain the fatality at such a young age.
Identifying the source of infection is important to understand how the case may have acquired his H7N9 infection. The high positive rates of H7N9 at the two LPMs (14.6 % and 18.5 %) suggest that the H7N9 virus might be contaminating the markets and surrounding areas, providing potential for spread of the virus to the LPMs workers and/or shoppers. However, phylogenetic results did not indicate an LPM-A-oriented infection source; even X passed the entrance of LPM-A every day. Because four genes (HA, PA, PB2, NP) of JZ-1 clustered with PD-2, X’s infection might originate from LPM-B; but X wasn’t exposed directly to the environment and poultry from PLM-B. X’s mother in law might carry H7N9 virus to X’s home through the contaminated water in LPM-B. Finally, there is still some uncertainty about avian-origin since LPM-related specimens were taken after, rather than before, his death.
On the hospital side, environmental specimens were taken after thorough clean-up. Unfortunately, specimens from the three febrile patients cared for by X and the two fatal cases (COPD-1 and SP-1) were not available. Most importantly, the positive anti-H7N9 HCWs (Y and Z) from the serological surveillance demonstrated that contaminated environment-to-human or human-to-human transmission in a hospital setting is likely  if HCWs did not have appropriate PPE while caring for infected patients. The low HAI serotiter of Z might be due to a shorter exposure. None of the six family members of X (including his 7-month-pregnant wife) were infected, showing that the person-to-person transmissibility within this family setting was still limited. The source of infection was not identified. The LPM-A was an unlikely source, but a contaminated environment, or an unidentified mild/asymptomatic H7N9 carrier were more probable.
To minimize the health threat to citizens , the Shanghai Government announced the closure of LPMs from January 31st to April 30th 2014. There have been no H7N9 cases in Shanghai since February. Based on our experience, we recommend: (1) during epidemics of H7N9, those HCWs who might be exposed to H7N9 cases are advised to take oseltamivir or other available drugs against H7N9 viruses in advance; (2) implementing rigorous standard operating procedures for infection control practices, including PPE, traffic control , and evaluations thereafter; (3) enhancing surveillance by reporting of any HCWs who develop ILI; (4) avoiding possible cross-transmission among HCWs, patients, and visitors, particularly the immunocompromised and/or those with other co-morbidities [18, 19]; and (5) during H7N9 epidemics, H7N9 tests need to be performed on all severe cases of respiratory infection, severe pneumonia cases in particular, even these cases have no obvious epidemiologic exposures.
All those discussed individuals provided written consents for the publication of this information and any accompanying images.
case fatality rate
a Pudong hospital in Shanghai
intensive care unit
real time reverse-transcriptase-polymerase-chain-reaction
chronic obstructive pulmonary disease
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med. 2013;368:1888–97.
Li Q, Zhou L, Zhou M, Chen Z, Li F, Wu H, Xiang N, Chen E, Tang F, Wang D, Meng L, Hong Z, Tu W, Cao Y, Li L, Ding F, Liu B, Wang M, Xie R, Gao R, Li X, Bai T, Zou S, He J, Hu J, Xu Y, Chai C, Wang S, Gao Y, Jin L, Zhang Y, Lou H, Yu H, He J, Li Q, Wang X, Gao L, Pang X, Liu G, Yan Y, Yuan H, Shu Y, Yang W, Wang Y, Wu F, Uyeki MT, Feng Z. Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China. N Engl J Med. 2014;370:520–32.
Chen C, Lu FC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.
World Health Organization: Real-time RT-PCR Protocol for the Detection of Avian Influenza A (H7N9) Virus. 2013. http://www.who.int/influenza/gisrs_laboratory/cnic_realtime_rt_pcr_protocol_a_h7n9.pdf?ua = 1. Accessed 8 Apr 2013.
World Health Organization: Serological detection of avian influenza A(H7N9) virus infections by modified horse red blood cells haemagglutination-inhibition assay. 2013. http://www.who.int/entity/influenza/gisrs_laboratory/cnic_serological_diagnosis_hai_a_h7n9_20131220.pdf?ua=1. Accessed 20 Dec 2013.
Hoang Vu MP, Nguyen CT, Nguyen Le KH, Nguyen TK, Le QM. Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009–2012. Western Pac Surveill Response J. 2013;4:25–9.
Zhao B, Zhang X, Zhu W, Teng Z, Yu X, Gao Y, Wu D, Pei E, Yuan Z, Yang L, Wang D, Shu Y, Wu F. Novel Avian Influenza A(H7N9) Virus in Tree Sparrow, Shanghai, China, 2013. Emerg Infect Dis. 2014;20:850–3.
Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus ADME ,Fouchier RAM. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012;336:1534–41.
Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012;486:420–8.
Ren YY, Yin YY, Li WQ, Lin Y, Liu T, Wang S, Zhang SY, Li Z, Wang XJ, Bi ZQ. Risk factors associated with severe manifestations of 2009 pandemic influenza A (H1N1) infection in China: a case–control study. Virol J. 2013;10:149.
The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N EnglJ Med. 2009;361:1925–34.
Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med. 2009;2009(361):1935–44.
Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, Lu SH, Yang YD, Fang Q, Shen YZ, Xi XM, Gu Q, Zhou XM, Qu HP, Yan Z, Li FM, Zhao W, Gao ZC, Wang GF, Ruan LX, Wang WH, Ye J, Cao HF, Li XW, Zhang WH, Fang XC, He J, Liang WF, Xie J, Zeng M, Wu X, Li J, Xia Q, Jin Z, Chen Q, Tang C, Zhang Z, Hou B, Feng Z, Sheng J, Zhong N, Li L. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med. 2013;368:2277–85.
Ramos I, Bernal-Rubio D, Durham N, Belicha-Villanueva A, Lowen AC, Steel J, Fernandez-Sesma A. Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J Virol. 2011;85:4421–31.
Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen vV, Pham TS, Vo CD, Le TQ, Ngo TT, Dao BK, Le PP, Nguyen TT, Hoang TL, Cao VT, Le TG, Nguyen DT, Le HN, Nguyen KT, Le HS, Le VT, Christiane D, Tran TT, Menno de J, Schultsz C, Cheng P, Lim W, Horby P, Farrar J. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004;350:1179–88.
Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, Wong SS, Farooqui A, Wang J, Banner D, Chen R, Zheng R, Zhou J, Zhang Y, Hong W, Dong W, Cai Q, Roehrl MH, Huang SS, Kelvin AA, Yao T, Zhou B, Chen X, Leung GM, Poon LL, Webster RG, Webby RJ, Peiris JS, Guan Y, Shu Y. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science. 2013;341:183–6.
Yu H, Wu JT, Cowling BJ, Liao Q, Fang VJ, Zhou S, Wu P, Zhou H, Lau EH, Guo D, Ni MY, Peng Z, Feng L, Jiang H, Luo H, Li Q, Feng Z, Wang Y, Yang W, Leung GM. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet. 2014;383:541–8.
World Health Organization: Opening statement by Dr Keiji Fukuda, WHO's Assistant Director-General for Health Security. 2013. http://www.wpro.who.int/china/mediacentre/speeches/2013/20130424/en/. Accessed 24 Apr 2013.
Osterholm MT. Preparing for the next pandemic. N Engl J Med. 2005;352:1839–42.
We would like to sincerely thank public health professionals at Pudong District CDC, Shanghai, China for their assistance in epidemiological investigation. The discussion inputs from Dr. Jonathan Gubbay from Public Health of Ontario, Canada, Dr. Yipu Lin from MRC National Institute for Medical Research, U.K., Dr. Barry T. Rouse from the University of Tennessee, U.S.A., Dr. Shelan Liu from Zhejiang-CDC in China, Dr. Muh-Yong Yen from National Yang-Ming University, Taipei, and Dr. Cheng-Chung Fang from National Taiwan University (NTU) Hospital, Dr. Hsin-Fu Liu from Mackay Memorial Hospital, Taipei, and Dr. Chang-Chun David Lee from NTU College of Public Health, are highly appreciated. We also like to express our sincere gratitude to Mr. Johnathan Kao, Ms. Mr. Elias F. Onyoh and Mr. Kent M. Suárez for their English editing. The work was supported by grants from the Shanghai Municipal Commission of Health & Family Planning: Shanghai Public Health Professional Overseas Training Grant (No. GWHW2012105) and Key Discipline: Epidemiology (No. 12GWZX0101) and 2013QLG001 and the Ministry of Science & Technology of China (KJYJ-2013-01-01-01 and KJYJ-2013-01-05).
The authors declare that they have no competing interests.
FW designed the study with help of CK. HP, JH, JC and QP designed the protocol of investigation, set up the field epidemiology, and conducted clinical investigation, respectively; XZ and ZT were responsible for experimental design, virus isolation, HAIs and rRT-PCR testing, and data analysis. All other co-authors participated in collection and management of data. HP wrote the manuscript. CK and FW helped in manuscript revision.
Fan Wu is the correspondence author of this article; Chwan-Chuen King is theco-correspondence author of this article.
* Correspondence: email@example.com; firstname.lastname@example.org Hao Pan, Xi Zhang, Jiayu Hu, Jian Chen contributed equally to this work.